(Q44622051)

English

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial

scientific article published on 4 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

heart failure with reduced ejection fraction

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

4 December 2017

Gregg C. Fonarow

5

1 reference

Europe PubMed Central

4 December 2017

Aldo P. Maggioni

7

1 reference

Europe PubMed Central

4 December 2017

Mihai Gheorghiade

14

object named as

Mihai Gheorghiade

1 reference

Europe PubMed Central

4 December 2017

Liliana Grinfeld

11

object named as

Liliana Grinfeld

1 reference

Europe PubMed Central

4 December 2017

13

object named as

Faiez Zannad

1 reference

Europe PubMed Central

4 December 2017

9

object named as

Karl Swedberg

1 reference

Europe PubMed Central

4 December 2017

Marvin A. Konstam

4

object named as

Marvin A Konstam

1 reference

Europe PubMed Central

4 December 2017

Andrew P. Ambrosy

1

object named as

Andrew P Ambrosy

1 reference

Europe PubMed Central

4 December 2017

3

object named as

Sadiya Khan

1 reference

Europe PubMed Central

4 December 2017

EVEREST Trial Investigators

15

object named as

EVEREST Trial Investigators

1 reference

Europe PubMed Central

4 December 2017

James E Udelson

12

object named as

James E Udelson

1 reference

Europe PubMed Central

4 December 2017

author name string

Brian Traver

6

1 reference

Europe PubMed Central

4 December 2017

Thomas Cook

8

1 reference

Europe PubMed Central

4 December 2017

John C Burnett

10

1 reference

Europe PubMed Central

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 January 2013

1 reference

Europe PubMed Central

4 December 2017

European Heart Journal

1 reference

Europe PubMed Central

4 December 2017

34

1 reference

Europe PubMed Central

4 December 2017

11

1 reference

Europe PubMed Central

4 December 2017

835-843

1 reference

Europe PubMed Central

4 December 2017

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Heart failure-related hospitalization in the U.S., 1979 to 2004.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

HFSA 2010 Comprehensive Heart Failure Practice Guideline

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Targeted vascular delivery of antisense molecules using intravenous microbubbles

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Does this dyspneic patient in the emergency department have congestive heart failure?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

A proposed model for initial assessment and management of acute heart failure syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Hospitalizations for heart failure in the United States--a sign of hope

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS444

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHS444

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44622051&oldid=2029549005"